knowledge -WSS

knowledge

author：leisure time 2025-09-29 10:40:27 - browse：7816

President Joe Biden talks in the Roosevelt Room of the White House, in front of a painting of Theodore Roosevelt on a horse back — politics coverage from STAT — President Biden MANDEL NGAN/AFP via Getty Images

WASHINGTON — The White House is throwing its support behind a controversial authority that allows the government to undermine patent rights for certain high-priced medicines. It’s an early step that could have major ramifications for the American pharmaceutical industry, depending on whether and how federal officials actually use the authority.

The administration issued a framework for the National Institutes of Health to more broadly use so-called “march-in rights” — a policy that allows it to invalidate patent rights from drugmakers whose products rely on federally funded research. The framework lays out when the agency might assert this authority, and endorse using a drug’s price in that determination.

“We’ll make clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House National Economic Advisor Lael Brainard told reporters. “These authorities are in existing laws, the last administration just didn’t want to allow them to be used in this way.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： The Readout: Lenmeldy, GLP

entertainment

WSS

'Screen and refer' systems are hurting patients

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Undocumented workers face uncertainty as immigration law takes effect in Florida

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Food as medicine: Medically tailored meals may get standardized

Study says nonprofit hospitals fall short in charity care spending

hotspot

knowledge

hotspot

At least 13 dead in Texas as scorching temps continue

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Cancer drug shortages should be causing more outrage

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

States should stop sabotaging methadone treatment reform

Psychedelics group wrestles with new pharma identity

Crowdfunding for unproven stem cell procedures spreads misinformation

Virginia high school admissions case could be legal follow

Oprah kicked off a national conversation on obesity. Let's have it

hotspot

Abortion pill Supreme Court ruling could impact entire drug industry

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Canadians with cystic fibrosis outlive Americans by a decade

Abortion pill Supreme Court ruling could impact entire drug industry

Study says nonprofit hospitals fall short in charity care spending

Canadians with cystic fibrosis outlive Americans by a decade

entertainment

Wikipedia

leisure time

explore